• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sutro Biopharma Inc (NQ: STRO )

    3.970 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.970
    Bid (Size) 3.970 (10)
    Ask (Size) 5.500 (1)
    Prev. Close 3.970
    Today's Range 3.970 - 3.970
    52wk Range 2.005 - 5.880
    Shares Outstanding 60,416,916
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
    Via Benzinga

    Performance

    YTD
    -13.13%
    -13.13%
    1 Month
    +30.16%
    +30.16%
    3 Month
    +6.15%
    +6.15%
    6 Month
    -8.53%
    -8.53%
    1 Year
    -10.79%
    -10.79%

    More News

    Read More
    Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
    Via Benzinga
    What's Going On With Sutro Biopharma (STRO) Stock?
    Via Benzinga
    Navigating 4 Analyst Ratings For Sutro Biopharma
    Via Benzinga
    Expert Ratings for Sutro Biopharma
    Via Benzinga
    STRO Stock Earnings: Sutro Biopharma Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Where Sutro Biopharma Stands With Analysts
    Via Benzinga
    5 Analysts Have This to Say About Sutro Biopharma
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
    From Vaxcyte, Inc.
    Via GlobeNewswire
    Where Sutro Biopharma Stands With Analysts
    Via Benzinga
    6 Analysts Have This to Say About Sutro Biopharma
    Via Benzinga
    Sutro Biopharma Earnings Perspective: Return On Capital Employed
    Via Benzinga
    Where Sutro Biopharma Stands With Analysts
    Via Benzinga
    Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.